Global Nuclide Drugs Market Growth (Status and Outlook) 2026-2032

September 2026 | 109 pages | ID: G368C003C75AEN
LP Information

Abstracts

The global Nuclide Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Nuclide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Nuclide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Nuclide Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Nuclide Drugs players cover GE Healthcare, Cardinal Health, Curium Pharma, Lantheus Medical Imaging, Inc., Eczac?ba?? Monrol Nuclear Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LPI (LP Information)' newest research report, the “Nuclide Drugs Industry Forecast” looks at past sales and reviews total world Nuclide Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Nuclide Drugs sales for 2026 through 2032. With Nuclide Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclide Drugs industry.

This Insight Report provides a comprehensive analysis of the global Nuclide Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nuclide Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclide Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclide Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclide Drugs.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclide Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Technetium-99
• Iodine-123
• Iodine-125
• Iodine-131
• Fluorine-18
• Gallium-67
• Others

Segmentation by Application:

• Therapeutic Use
• Diagnostic Use

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GE Healthcare
• Cardinal Health
• Curium Pharma
• Lantheus Medical Imaging, Inc.
• Eczac?ba?? Monrol Nuclear Products
• Novartis International AG
• Siemens
• China Isotope & Radiation
• Yantai Dongcheng Pharmaceutical
• Jubilant Life Sciences
• Bracco

Contents

1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Nuclide Drugs Market Size (2021-2032)
  2.1.2 Nuclide Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Nuclide Drugs by Country/Region (2021, 2025 & 2032)
  2.2 Nuclide Drugs Segment by Type
  2.2.1 Technetium-99
  2.2.2 Iodine-123
  2.2.3 Iodine-125
  2.2.4 Iodine-131
  2.2.5 Fluorine-18
  2.2.6 Gallium-67
  2.2.7 Others
  2.2.8 Nuclide Drugs Market Size by Type
  2.2.8.1 Nuclide Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032)
  2.2.8.2 Global Nuclide Drugs Market Size Market Share by Type (2021-2026)
  2.3 Nuclide Drugs Segment by Application
  2.3.1 Therapeutic Use
  2.3.2 Diagnostic Use
  2.3.3 Nuclide Drugs Market Size by Application
  2.3.3.1 Nuclide Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
  2.3.3.2 Global Nuclide Drugs Market Size Market Share by Application (2021-2026)

3 NUCLIDE DRUGS MARKET SIZE BY PLAYER

  3.1 Nuclide Drugs Market Size Market Share by Player
  3.1.1 Global Nuclide Drugs Revenue by Player (2021-2026)
  3.1.2 Global Nuclide Drugs Revenue Market Share by Player (2021-2026)
  3.2 Global Nuclide Drugs Key Players Head office and Products Offered
  3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.4 New Products and Potential Entrants
  3.5 Mergers & Acquisitions, Expansion

4 NUCLIDE DRUGS BY REGION

  4.1 Nuclide Drugs Market Size by Region (2021-2026)
  4.2 Global Nuclide Drugs Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Nuclide Drugs Market Size Growth (2021-2026)
  4.4 APAC Nuclide Drugs Market Size Growth (2021-2026)
  4.5 Europe Nuclide Drugs Market Size Growth (2021-2026)
  4.6 Middle East & Africa Nuclide Drugs Market Size Growth (2021-2026)

5 AMERICAS

  5.1 Americas Nuclide Drugs Market Size by Country (2021-2026)
  5.2 Americas Nuclide Drugs Market Size by Type (2021-2026)
  5.3 Americas Nuclide Drugs Market Size by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Nuclide Drugs Market Size by Region (2021-2026)
  6.2 APAC Nuclide Drugs Market Size by Type (2021-2026)
  6.3 APAC Nuclide Drugs Market Size by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia

7 EUROPE

  7.1 Europe Nuclide Drugs Market Size by Country (2021-2026)
  7.2 Europe Nuclide Drugs Market Size by Type (2021-2026)
  7.3 Europe Nuclide Drugs Market Size by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Nuclide Drugs by Region (2021-2026)
  8.2 Middle East & Africa Nuclide Drugs Market Size by Type (2021-2026)
  8.3 Middle East & Africa Nuclide Drugs Market Size by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 GLOBAL NUCLIDE DRUGS MARKET FORECAST

  10.1 Global Nuclide Drugs Forecast by Region (2027-2032)
  10.1.1 Global Nuclide Drugs Forecast by Region (2027-2032)
  10.1.2 Americas Nuclide Drugs Forecast
  10.1.3 APAC Nuclide Drugs Forecast
  10.1.4 Europe Nuclide Drugs Forecast
  10.1.5 Middle East & Africa Nuclide Drugs Forecast
  10.2 Americas Nuclide Drugs Forecast by Country (2027-2032)
  10.2.1 United States Market Nuclide Drugs Forecast
  10.2.2 Canada Market Nuclide Drugs Forecast
  10.2.3 Mexico Market Nuclide Drugs Forecast
  10.2.4 Brazil Market Nuclide Drugs Forecast
  10.3 APAC Nuclide Drugs Forecast by Region (2027-2032)
  10.3.1 China Nuclide Drugs Market Forecast
  10.3.2 Japan Market Nuclide Drugs Forecast
  10.3.3 Korea Market Nuclide Drugs Forecast
  10.3.4 Southeast Asia Market Nuclide Drugs Forecast
  10.3.5 India Market Nuclide Drugs Forecast
  10.3.6 Australia Market Nuclide Drugs Forecast
  10.4 Europe Nuclide Drugs Forecast by Country (2027-2032)
  10.4.1 Germany Market Nuclide Drugs Forecast
  10.4.2 France Market Nuclide Drugs Forecast
  10.4.3 UK Market Nuclide Drugs Forecast
  10.4.4 Italy Market Nuclide Drugs Forecast
  10.4.5 Russia Market Nuclide Drugs Forecast
  10.5 Middle East & Africa Nuclide Drugs Forecast by Region (2027-2032)
  10.5.1 Egypt Market Nuclide Drugs Forecast
  10.5.2 South Africa Market Nuclide Drugs Forecast
  10.5.3 Israel Market Nuclide Drugs Forecast
  10.5.4 Turkey Market Nuclide Drugs Forecast
  10.6 Global Nuclide Drugs Forecast by Type (2027-2032)
  10.7 Global Nuclide Drugs Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Nuclide Drugs Forecast

11 KEY PLAYERS ANALYSIS

  11.1 GE Healthcare
  11.1.1 GE Healthcare Company Information
  11.1.2 GE Healthcare Nuclide Drugs Product Offered
  11.1.3 GE Healthcare Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 GE Healthcare Main Business Overview
  11.1.5 GE Healthcare Latest Developments
  11.2 Cardinal Health
  11.2.1 Cardinal Health Company Information
  11.2.2 Cardinal Health Nuclide Drugs Product Offered
  11.2.3 Cardinal Health Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Cardinal Health Main Business Overview
  11.2.5 Cardinal Health Latest Developments
  11.3 Curium Pharma
  11.3.1 Curium Pharma Company Information
  11.3.2 Curium Pharma Nuclide Drugs Product Offered
  11.3.3 Curium Pharma Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Curium Pharma Main Business Overview
  11.3.5 Curium Pharma Latest Developments
  11.4 Lantheus Medical Imaging, Inc.
  11.4.1 Lantheus Medical Imaging, Inc. Company Information
  11.4.2 Lantheus Medical Imaging, Inc. Nuclide Drugs Product Offered
  11.4.3 Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Lantheus Medical Imaging, Inc. Main Business Overview
  11.4.5 Lantheus Medical Imaging, Inc. Latest Developments
  11.5 Eczac?ba?? Monrol Nuclear Products
  11.5.1 Eczac?ba?? Monrol Nuclear Products Company Information
  11.5.2 Eczac?ba?? Monrol Nuclear Products Nuclide Drugs Product Offered
  11.5.3 Eczac?ba?? Monrol Nuclear Products Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Eczac?ba?? Monrol Nuclear Products Main Business Overview
  11.5.5 Eczac?ba?? Monrol Nuclear Products Latest Developments
  11.6 Novartis International AG
  11.6.1 Novartis International AG Company Information
  11.6.2 Novartis International AG Nuclide Drugs Product Offered
  11.6.3 Novartis International AG Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Novartis International AG Main Business Overview
  11.6.5 Novartis International AG Latest Developments
  11.7 Siemens
  11.7.1 Siemens Company Information
  11.7.2 Siemens Nuclide Drugs Product Offered
  11.7.3 Siemens Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Siemens Main Business Overview
  11.7.5 Siemens Latest Developments
  11.8 China Isotope & Radiation
  11.8.1 China Isotope & Radiation Company Information
  11.8.2 China Isotope & Radiation Nuclide Drugs Product Offered
  11.8.3 China Isotope & Radiation Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 China Isotope & Radiation Main Business Overview
  11.8.5 China Isotope & Radiation Latest Developments
  11.9 Yantai Dongcheng Pharmaceutical
  11.9.1 Yantai Dongcheng Pharmaceutical Company Information
  11.9.2 Yantai Dongcheng Pharmaceutical Nuclide Drugs Product Offered
  11.9.3 Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Yantai Dongcheng Pharmaceutical Main Business Overview
  11.9.5 Yantai Dongcheng Pharmaceutical Latest Developments
  11.10 Jubilant Life Sciences
  11.10.1 Jubilant Life Sciences Company Information
  11.10.2 Jubilant Life Sciences Nuclide Drugs Product Offered
  11.10.3 Jubilant Life Sciences Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Jubilant Life Sciences Main Business Overview
  11.10.5 Jubilant Life Sciences Latest Developments
  11.11 Bracco
  11.11.1 Bracco Company Information
  11.11.2 Bracco Nuclide Drugs Product Offered
  11.11.3 Bracco Nuclide Drugs Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Bracco Main Business Overview
  11.11.5 Bracco Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nuclide Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Nuclide Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Technetium-99
Table 4. Major Players of Iodine-123
Table 5. Major Players of Iodine-125
Table 6. Major Players of Iodine-131
Table 7. Major Players of Fluorine-18
Table 8. Major Players of Gallium-67
Table 9. Major Players of Others
Table 10. Nuclide Drugs Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Nuclide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 12. Global Nuclide Drugs Market Size Market Share by Type (2021-2026)
Table 13. Nuclide Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Nuclide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 15. Global Nuclide Drugs Market Size Market Share by Application (2021-2026)
Table 16. Global Nuclide Drugs Revenue by Player (2021-2026) & ($ millions)
Table 17. Global Nuclide Drugs Revenue Market Share by Player (2021-2026)
Table 18. Nuclide Drugs Key Players Head office and Products Offered
Table 19. Nuclide Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Nuclide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 23. Global Nuclide Drugs Market Size Market Share by Region (2021-2026)
Table 24. Global Nuclide Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 25. Global Nuclide Drugs Revenue Market Share by Country/Region (2021-2026)
Table 26. Americas Nuclide Drugs Market Size by Country (2021-2026) & ($ millions)
Table 27. Americas Nuclide Drugs Market Size Market Share by Country (2021-2026)
Table 28. Americas Nuclide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 29. Americas Nuclide Drugs Market Size Market Share by Type (2021-2026)
Table 30. Americas Nuclide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 31. Americas Nuclide Drugs Market Size Market Share by Application (2021-2026)
Table 32. APAC Nuclide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 33. APAC Nuclide Drugs Market Size Market Share by Region (2021-2026)
Table 34. APAC Nuclide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 35. APAC Nuclide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 36. Europe Nuclide Drugs Market Size by Country (2021-2026) & ($ millions)
Table 37. Europe Nuclide Drugs Market Size Market Share by Country (2021-2026)
Table 38. Europe Nuclide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 39. Europe Nuclide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 40. Middle East & Africa Nuclide Drugs Market Size by Region (2021-2026) & ($ millions)
Table 41. Middle East & Africa Nuclide Drugs Market Size by Type (2021-2026) & ($ millions)
Table 42. Middle East & Africa Nuclide Drugs Market Size by Application (2021-2026) & ($ millions)
Table 43. Key Market Drivers & Growth Opportunities of Nuclide Drugs
Table 44. Key Market Challenges & Risks of Nuclide Drugs
Table 45. Key Industry Trends of Nuclide Drugs
Table 46. Global Nuclide Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 47. Global Nuclide Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 48. Global Nuclide Drugs Market Size Forecast by Type (2027-2032) & ($ millions)
Table 49. Global Nuclide Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 50. GE Healthcare Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 51. GE Healthcare Nuclide Drugs Product Offered
Table 52. GE Healthcare Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. GE Healthcare Main Business
Table 54. GE Healthcare Latest Developments
Table 55. Cardinal Health Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 56. Cardinal Health Nuclide Drugs Product Offered
Table 57. Cardinal Health Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Cardinal Health Main Business
Table 59. Cardinal Health Latest Developments
Table 60. Curium Pharma Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 61. Curium Pharma Nuclide Drugs Product Offered
Table 62. Curium Pharma Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Curium Pharma Main Business
Table 64. Curium Pharma Latest Developments
Table 65. Lantheus Medical Imaging, Inc. Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 66. Lantheus Medical Imaging, Inc. Nuclide Drugs Product Offered
Table 67. Lantheus Medical Imaging, Inc. Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Lantheus Medical Imaging, Inc. Main Business
Table 69. Lantheus Medical Imaging, Inc. Latest Developments
Table 70. Eczac?ba?? Monrol Nuclear Products Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 71. Eczac?ba?? Monrol Nuclear Products Nuclide Drugs Product Offered
Table 72. Eczac?ba?? Monrol Nuclear Products Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Eczac?ba?? Monrol Nuclear Products Main Business
Table 74. Eczac?ba?? Monrol Nuclear Products Latest Developments
Table 75. Novartis International AG Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 76. Novartis International AG Nuclide Drugs Product Offered
Table 77. Novartis International AG Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Novartis International AG Main Business
Table 79. Novartis International AG Latest Developments
Table 80. Siemens Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 81. Siemens Nuclide Drugs Product Offered
Table 82. Siemens Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Siemens Main Business
Table 84. Siemens Latest Developments
Table 85. China Isotope & Radiation Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 86. China Isotope & Radiation Nuclide Drugs Product Offered
Table 87. China Isotope & Radiation Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. China Isotope & Radiation Main Business
Table 89. China Isotope & Radiation Latest Developments
Table 90. Yantai Dongcheng Pharmaceutical Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 91. Yantai Dongcheng Pharmaceutical Nuclide Drugs Product Offered
Table 92. Yantai Dongcheng Pharmaceutical Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Yantai Dongcheng Pharmaceutical Main Business
Table 94. Yantai Dongcheng Pharmaceutical Latest Developments
Table 95. Jubilant Life Sciences Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 96. Jubilant Life Sciences Nuclide Drugs Product Offered
Table 97. Jubilant Life Sciences Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Jubilant Life Sciences Main Business
Table 99. Jubilant Life Sciences Latest Developments
Table 100. Bracco Details, Company Type, Nuclide Drugs Area Served and Its Competitors
Table 101. Bracco Nuclide Drugs Product Offered
Table 102. Bracco Nuclide Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Bracco Main Business
Table 104. Bracco Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Nuclide Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nuclide Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Nuclide Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Nuclide Drugs Sales Market Share by Country/Region (2025)
Figure 8. Nuclide Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Nuclide Drugs Market Size Market Share by Type in 2025
Figure 10. Nuclide Drugs in Therapeutic Use
Figure 11. Global Nuclide Drugs Market: Therapeutic Use (2021-2026) & ($ millions)
Figure 12. Nuclide Drugs in Diagnostic Use
Figure 13. Global Nuclide Drugs Market: Diagnostic Use (2021-2026) & ($ millions)
Figure 14. Global Nuclide Drugs Market Size Market Share by Application in 2025
Figure 15. Global Nuclide Drugs Revenue Market Share by Player in 2025
Figure 16. Global Nuclide Drugs Market Size Market Share by Region (2021-2026)
Figure 17. Americas Nuclide Drugs Market Size 2021-2026 ($ millions)
Figure 18. APAC Nuclide Drugs Market Size 2021-2026 ($ millions)
Figure 19. Europe Nuclide Drugs Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Nuclide Drugs Market Size 2021-2026 ($ millions)
Figure 21. Americas Nuclide Drugs Value Market Share by Country in 2025
Figure 22. United States Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Nuclide Drugs Market Size Market Share by Region in 2025
Figure 27. APAC Nuclide Drugs Market Size Market Share by Type (2021-2026)
Figure 28. APAC Nuclide Drugs Market Size Market Share by Application (2021-2026)
Figure 29. China Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. India Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Nuclide Drugs Market Size Market Share by Country in 2025
Figure 36. Europe Nuclide Drugs Market Size Market Share by Type (2021-2026)
Figure 37. Europe Nuclide Drugs Market Size Market Share by Application (2021-2026)
Figure 38. Germany Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 39. France Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Nuclide Drugs Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Nuclide Drugs Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Nuclide Drugs Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Nuclide Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 52. APAC Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 53. Europe Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 55. United States Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 56. Canada Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 57. Mexico Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 58. Brazil Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 59. China Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 60. Japan Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 61. Korea Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 63. India Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 64. Australia Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 65. Germany Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 66. France Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 67. UK Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 68. Italy Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 69. Russia Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 70. Egypt Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 71. South Africa Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 72. Israel Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 73. Turkey Nuclide Drugs Market Size 2027-2032 ($ millions)
Figure 74. Global Nuclide Drugs Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Nuclide Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Nuclide Drugs Market Size 2027-2032 ($ millions)